Last updated on 6 May 2023
Owner Info
Iovance Biotherapeutics, Inc.
825 Industrial Road, Suite 400
San Carlos CA 94070, UNITED STATES OF AMERICA
Serial Number
2333148 filed on 16 Sept 2022
Correspondent
Carla B. Oakley Morgan, Lewis & Bockius LLP
One Market, Spear Street Tower,
San Francisco CA 94105,
UNITED STATES OF AMERICA
2333148
16 Sept 2022
16 Sept 2032
WORD
18 Mar 2022
US
Status Date | Action Taken |
---|---|
6th May 2023 | International Registration in Australia Protected correspondence sent |
5th May 2023 | IP Right Registration Published |
5th May 2023 | Status change to Registered/Protected |
1st Mar 2023 | Application Accepted correspondence sent |
28th Feb 2023 | IP Right has been Examined |
28th Feb 2023 | IP Right Acceptance Published |
28th Feb 2023 | Status change to Accepted |
15th Feb 2023 | Awaiting examination |
15th Feb 2023 | Examination expedited |
9th Feb 2023 | IP Right Filed Published |